KPL Q1 FY27 results at a glance
KWALITY PHARMACEUTICALS L Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹162 cr |
|---|
| Revenue YoY | +45.6% |
|---|
| Operating profit | ₹36.03 cr |
|---|
| Operating margin | 22.2% |
|---|
| Net profit | ₹25.62 cr |
|---|
| Net profit YoY | +114.9% |
|---|
| Net profit QoQ | +1.3% |
|---|
| Net margin | 15.8% |
|---|
| Basic EPS | — |
|---|
| TTM revenue | ₹554 cr |
|---|
| TTM net profit | ₹81.05 cr |
|---|
| TTM net margin | 14.6% |
|---|
KPL Q1 FY27 results: what the numbers say
KWALITY PHARMACEUTICALS L (KPL) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹162 cr and a net profit of ₹25.62 cr, translating into earnings per share of —.
Compared with the same quarter a year earlier, revenue grew strongly by +45.6% and net profit grew sharply by +114.9%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹36.03 cr, an operating margin of 22.2% versus 17.4% a year ago — a gain of 4.8 percentage points.
KPL quarter-wise results table
Net profit
₹25.62 cr
+114.9% YoY
Operating profit
₹36.03 cr
+85.6% YoY
KWALITY PHARMACEUTICALS L (KPL) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹162 cr | ₹36.03 cr | ₹25.62 cr | 22.2% | 15.8% | — | +114.9% | +1.3% |
| Q4 FY262026-03-31 | ₹157 cr | ₹33.5 cr | ₹25.3 cr | 21.3% | 16.1% | — | — | +58.0% |
| Q3 FY262025-12-31 | ₹123 cr | ₹25.13 cr | ₹16.01 cr | 20.4% | 13.0% | — | — | +13.4% |
| Q2 FY262025-09-30 | ₹111 cr | ₹20.4 cr | ₹14.12 cr | 18.4% | 12.7% | — | — | +18.4% |
| Q1 FY262025-06-30 | ₹111 cr | ₹19.41 cr | ₹11.93 cr | 17.4% | 10.7% | — | — | — |
| TTM (last 4 quarters) | ₹554 cr | ₹115 cr | ₹81.05 cr | 20.8% | 14.6% | — | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
KPL quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
KWALITY PHARMACEUTICALS L quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹162 cr | ₹157 cr | ₹123 cr | ₹111 cr | ₹111 cr |
|---|
| Total expenses | ₹126 cr | ₹124 cr | ₹98.31 cr | ₹90.66 cr | ₹92.07 cr |
|---|
| Gross profit | ₹74.93 cr | ₹70.43 cr | ₹64.34 cr | ₹56.43 cr | ₹53.45 cr |
|---|
| Operating profit (EBIT) | ₹36.03 cr | ₹33.5 cr | ₹25.13 cr | ₹20.4 cr | ₹19.41 cr |
|---|
| Operating margin | 22.2% | 21.3% | 20.4% | 18.4% | 17.4% |
|---|
| Interest cost | ₹2.66 cr | ₹2.89 cr | ₹2.48 cr | ₹2.84 cr | ₹2.76 cr |
|---|
| Profit before tax | ₹33.99 cr | ₹31.67 cr | ₹22.35 cr | ₹18.45 cr | ₹17.03 cr |
|---|
| Tax expense | ₹8.36 cr | ₹6.36 cr | ₹6.35 cr | ₹4.33 cr | ₹5.11 cr |
|---|
| Effective tax rate | 24.6% | 20.1% | 28.4% | 23.5% | 30.0% |
|---|
| Net profit (PAT) | ₹25.62 cr | ₹25.3 cr | ₹16.01 cr | ₹14.12 cr | ₹11.93 cr |
|---|
| Net profit margin | 15.8% | 16.1% | 13.0% | 12.7% | 10.7% |
|---|
KPL results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +45.6% | — | — | — | — |
|---|
| Revenue QoQ | +3.3% | +27.3% | +11.2% | -0.4% | — |
|---|
| Operating profit YoY | +85.6% | — | — | — | — |
|---|
| Operating profit QoQ | +7.5% | +33.3% | +23.2% | +5.1% | — |
|---|
| Net profit YoY | +114.9% | — | — | — | — |
|---|
| Net profit QoQ | +1.3% | +58.0% | +13.4% | +18.4% | — |
|---|
| EPS YoY | — | — | — | — | — |
|---|
| EPS QoQ | — | — | — | — | — |
|---|
KPL annual results history
Full-year performance for KWALITY PHARMACEUTICALS L, useful for reading each quarter in context.
KWALITY PHARMACEUTICALS L annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹503 cr | ₹370 cr | ₹307 cr | ₹251 cr |
|---|
| Total expenses | ₹405 cr | ₹308 cr | ₹260 cr | ₹205 cr |
|---|
| Gross profit | ₹242 cr | ₹183 cr | ₹144 cr | ₹132 cr |
|---|
| Operating profit (EBIT) | ₹98.45 cr | ₹62.1 cr | ₹46.79 cr | ₹45.77 cr |
|---|
| Operating margin | 19.6% | 16.8% | 15.2% | 18.2% |
|---|
| Interest cost | ₹10.97 cr | ₹9.88 cr | ₹10.39 cr | ₹6.02 cr |
|---|
| Profit before tax | ₹89.49 cr | ₹54.14 cr | ₹31.1 cr | ₹25.57 cr |
|---|
| Tax expense | ₹22.15 cr | ₹14.34 cr | ₹7.48 cr | ₹6.29 cr |
|---|
| Effective tax rate | 24.7% | 26.5% | 24.1% | 24.6% |
|---|
| Net profit (PAT) | ₹67.35 cr | ₹39.85 cr | ₹23.8 cr | ₹19.37 cr |
|---|
| Net profit margin | 13.4% | 10.8% | 7.7% | 7.7% |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹162 cr against ₹111 cr in Q1 FY26, and ₹157 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +3.3%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹126 cr, or 77.8% of revenue, with operating profit grew +85.6% year on year.
Margins, tax and profitability
Net profit of ₹25.62 cr works out to a net margin of 15.8% compared with 10.7% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, KWALITY PHARMACEUTICALS L reported profit before tax of ₹33.99 cr, a tax charge of ₹8.36 cr (effective rate 24.6%), interest cost of ₹2.66 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹25.3 cr in Q4 FY26 to ₹25.62 cr in Q1 FY27, a change of +1.3%.
Trailing twelve months and annual context
Across the trailing four quarters KWALITY PHARMACEUTICALS L has generated revenue of ₹554 cr and net profit of ₹81.05 cr, a trailing net margin of 14.6%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹503 cr with net profit of ₹67.35 cr and EPS of —, versus the prior year where revenue grew +35.9% and profit grew +69.0%.
What to watch in the next KPL quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
KWALITY PHARMACEUTICALS L has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
KPL results coverage
No results report published for KPL yet — our desk covers each quarter within minutes of the filing.
KPL quarterly results FAQs
What were KWALITY PHARMACEUTICALS L (KPL) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), KWALITY PHARMACEUTICALS L reported revenue of ₹162 cr and net profit of ₹25.62 cr, a change of +114.9% year on year on +45.6% revenue growth. EPS stood at —.
What is KPL profit margin in Q1 FY27?
KWALITY PHARMACEUTICALS L posted a net profit margin of 15.8% and an operating margin of 22.2% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹554 cr and net profit ₹81.05 cr.
Did KPL results beat the previous quarter?
KWALITY PHARMACEUTICALS L net profit changed +1.3% quarter on quarter, from ₹25.3 cr in Q4 FY26 to ₹25.62 cr in Q1 FY27.
When are KWALITY PHARMACEUTICALS L (KPL) quarterly results?
KWALITY PHARMACEUTICALS L has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see KPL latest quarterly results?
Results coverage for KPL will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the KPL stock page.
What is KWALITY PHARMACEUTICALS L annual revenue and profit?
For FY26, KWALITY PHARMACEUTICALS L reported full-year revenue of ₹503 cr and net profit of ₹67.35 cr, with EPS of —.
How many quarterly results has KPL declared recently?
Past results dates for KPL will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
